Sartorius AG Share Price Deutsche Boerse AG

Equities

SRT3

DE0007165631

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 09:32:42 18/07/2024 BST 5-day change 1st Jan Change
246.8 EUR +1.11% Intraday chart for Sartorius AG +0.49% -26.59%

Financials

Sales 2024 * 3.53B 3.86B 297B Sales 2025 * 3.92B 4.29B 330B Capitalization 15.19B 16.61B 1,278B
Net income 2024 * 241M 263M 20.27B Net income 2025 * 368M 402M 30.95B EV / Sales 2024 * 5.42 x
Net Debt 2024 * 3.94B 4.31B 331B Net Debt 2025 * 3.7B 4.05B 311B EV / Sales 2025 * 4.82 x
P/E ratio 2024 *
68.9 x
P/E ratio 2025 *
47.4 x
Employees 14,614
Yield 2024 *
0.36%
Yield 2025 *
0.44%
Free-Float 35.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.96%
1 week+0.49%
Current month+11.57%
1 month+0.78%
3 months-11.20%
6 months-17.32%
Current year-26.59%
More quotes
1 week
238.40
Extreme 238.4
244.90
1 month
203.80
Extreme 203.8
244.90
Current year
203.80
Extreme 203.8
382.60
1 year
203.80
Extreme 203.8
382.60
3 years
203.80
Extreme 203.8
625.00
5 years
158.30
Extreme 158.3
625.00
10 years
18.94
Extreme 18.9423
625.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 30/04/99
Chief Tech/Sci/R&D Officer 59 31/12/94
Chief Operating Officer 67 31/12/00
Members of the board TitleAgeSince
Director/Board Member 69 31/12/19
Director/Board Member 75 28/11/11
Director/Board Member 58 05/04/17
More insiders
Date Price Change Volume
18/07/24 244.9 +0.33% 53
17/07/24 244.1 +2.39% 291
16/07/24 238.4 -1.77% 0
15/07/24 242.7 +1.68% 15
12/07/24 238.7 -2.05% 153

Delayed Quote Deutsche Boerse AG, July 18, 2024 at 07:29 am

More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
243.6 EUR
Average target price
309 EUR
Spread / Average Target
+26.85%
Consensus